What does this research mean for the field?

PRO-based remote symptom monitoring interventions in cancer RCTs exhibit substantial methodological heterogeneity and critical reporting gaps that obscure their active ingredients, necessitating standardized reporting to enable replication and optimization. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate and characterize the design features and methodological architecture of PRO-based remote symptom monitoring interventions with alert-triggered clinical responses in cancer RCTs.

August 24, 2026Diseases of the EsophagusOpen Access

P1.068. Design Features of PRO-Based Remote Symptom Monitoring Interventions With Alert-Triggered Clinical Response in Cancer RCTs: A Systematic Review

View Full Paper

Ask AI

Bookmark

Authors

SLSimiao Lu YZYi Zhu YHYongtao Han

Discussion

Member takes

Overview

Systematic review reveals substantial methodological heterogeneity and reporting gaps in PRO-based remote symptom monitoring across cancer trials, highlighting the need for standardized reporting.

Key Points

To evaluate and characterize the design features and methodological architecture of PRO-based remote symptom monitoring interventions with alert-triggered clinical responses in cancer RCTs.
Searched six databases and ClinicalTrials.gov through October 2025 for RCTs evaluating PRO-based remote symptom monitoring with alert or clinical response mechanisms in cancer.
Three independent reviewers screened studies and extracted data using a 75-variable framework spanning five analytical domains.
Identified 61 unique RCTs (N=25,795; 18 countries) utilizing over 20 PRO instruments, with NCI PRO-CTCAE being the most common (19.7%), smartphone apps the leading platform (31.1%), and EHR integration achieved in only 21.3%.
Alert systems were used in 93.4% of trials (tiered architectures in 23.0%), standard response protocols in 73.8%, response timeliness documented in 62.3%, and zero trials documented a validated triage tool.
Reporting completeness was not associated with trial outcome (OR 1.05, 95% CI 0.63–1.74), and analysis of null trials identified four mechanistic failure archetypes.

Cite This Study

Lu et al. (2026) studied this question.

synapsesocial.com/papers/6a8c00c1bca056c88e6dfb7a https://doi.org/10.1093/dote/doag077.216

View Full Paper

Ask AI

Bookmark

August 24, 2026Diseases of the EsophagusOpen Access

P1.068. Design Features of PRO-Based Remote Symptom Monitoring Interventions With Alert-Triggered Clinical Response in Cancer RCTs: A Systematic Review

View Full Paper

Ask AI

Bookmark

Authors

SLSimiao Lu YZYi Zhu YHYongtao Han

Discussion

Member takes

Overview

Systematic review reveals substantial methodological heterogeneity and reporting gaps in PRO-based remote symptom monitoring across cancer trials, highlighting the need for standardized reporting.

Key Points

To evaluate and characterize the design features and methodological architecture of PRO-based remote symptom monitoring interventions with alert-triggered clinical responses in cancer RCTs.
Searched six databases and ClinicalTrials.gov through October 2025 for RCTs evaluating PRO-based remote symptom monitoring with alert or clinical response mechanisms in cancer.
Three independent reviewers screened studies and extracted data using a 75-variable framework spanning five analytical domains.
Identified 61 unique RCTs (N=25,795; 18 countries) utilizing over 20 PRO instruments, with NCI PRO-CTCAE being the most common (19.7%), smartphone apps the leading platform (31.1%), and EHR integration achieved in only 21.3%.
Alert systems were used in 93.4% of trials (tiered architectures in 23.0%), standard response protocols in 73.8%, response timeliness documented in 62.3%, and zero trials documented a validated triage tool.
Reporting completeness was not associated with trial outcome (OR 1.05, 95% CI 0.63–1.74), and analysis of null trials identified four mechanistic failure archetypes.

Cite This Study

Lu et al. (2026) studied this question.

synapsesocial.com/papers/6a8c00c1bca056c88e6dfb7a https://doi.org/10.1093/dote/doag077.216

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark